arrow_back Back to App

US-Israel Cooperation: Advancing Health Technologies

This act aims to foster cooperation between the United States and Israel in the development of health technologies. It authorizes funding for research into new drugs, vaccines, diagnostics, and telemedicine, potentially leading to improved healthcare and access to innovative solutions for citizens.
Key points
Authorizes $4 million annually for the development of health technologies, including artificial intelligence, drugs, and vaccines.
Supports research into emerging infectious diseases, personalized medicine, and data utilization in healthcare.
Cooperation with Israel requires a matching financial contribution from the Government of Israel.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4076
Sponsor: Rep. Pappas, Chris [D-NH-1]
Process start date: 2023-06-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

United States-Israel Health Technologies Cooperation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4076.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-13.

What are the main provisions?

Key points include:

  • Authorizes $4 million annually for the development of health technologies, including artificial intelligence, drugs, and vaccines.
  • Supports research into emerging infectious diseases, personalized medicine, and data utilization in healthcare.
  • Cooperation with Israel requires a matching financial contribution from the Government of Israel.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Pappas, Chris [D-NH-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Public Investments